The primary focus of the Barmada Laboratory is the molecular and pathologic overlap between amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and frontotemporal dementia (FTD). We are interested in the basic biology common to both disorders, and the cascade of events underpinning neural dysfunction, death and symptoms of disease. Our goal is to use this information to devise new and effective treatments for patients with ALS, FTD or both. To accomplish these objectives, we utilize a blend of technologies and disciplines, including molecular biology, neuroscience, fluorescence microscopy, and computer science to visualize neurodegeneration in real time and distinguish cause from effect.
The laboratory is made up of a mix postdoctoral fellows, graduate students, technicians, research specialists, software engineers and undergraduate students. 
Follow the link below for a list of relevant manuscripts from the Barmada laboratory and collaborators.
The laboratory is located in the A. Alfred Taubman Biomedical Sciences Research Building at the University of Michigan, Ann Arbor. Follow the link below for more information.